UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Does Delaying Surgical Treatment of BPH Affect Long-Term Outcomes?

Current bladder dysfunction reports, 2024-06, Vol.19 (2), p.95-99

2024

Volltextzugriff (PDF)

Juxtaglomerular Cell Tumor: A Rare, Curable Cause of Hypertension in a Young Patient

Urology (Ridgewood, N.J.), 2019-12, Vol.134, p.42-44

2019

Volltextzugriff (PDF)

Immunotherapy and Checkpoint Inhibitors in Urologic Cancer

Urologic clinics of North America, 2022-05, Vol.49 (2), p.323-334

2022

Volltextzugriff (PDF)

Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids

The Journal of biological chemistry, 2020-01, Vol.295 (1), p.263-274

2020

Volltextzugriff (PDF)

Pan-Urethral Condylomata Acuminata in an Immunocompromised Patient

Urology (Ridgewood, N.J.), 2019-10, Vol.132, p.18-21

2019

Volltextzugriff (PDF)

Abstract A14: Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer

Clinical cancer research, 2020-08, Vol.26 (15_Supplement), p.A14-A14

2020

Volltextzugriff (PDF)

Abstract B20: Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma

Clinical cancer research, 2020-08, Vol.26 (15_Supplement), p.B20-B20

2020

Volltextzugriff (PDF)

PD47-05 PREVALENCE OF ACTIONABLE GENOMIC ALTERATIONS AND THE USE OF TARGETED THERAPY IN METASTATIC UROTHELIAL CARCINOMA

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

PD47-03 CHARACTERIZING THE LANDSCAPE OF ACTIONABLE GENOMIC ALTERATIONS TO IDENTIFY OPPORTUNITIES FOR TARGETED THERAPY TRIALS IN PATIENTS WITH LOCALIZED BLADDER CANCER

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

PD12-12 PATIENT MATCHED GENOMIC ANALYSIS OF HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER SPECIMENS PRE- AND POST-BCG IMMUNOTHERAPY

The Journal of urology, 2020-04, Vol.203, p.e263-e264

2020

Volltextzugriff (PDF)

MP63-13 NEXT-GENERATION SEQUENCING REVEALS GENOMIC DIFFERENCES BETWEEN MALE AND FEMALE PATIENTS WITH UROTHELIAL CARCINOMA

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

MP57-10 CHARACTERIZATION OF MOLECULAR DIFFERENCES BETWEEN SMOKERS AND NON-SMOKERS WITH UROTHELIAL CARCINOMA

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

MP43-05 THE LANDSCAPE OF CLINICALLY ACTIONABLE GENOMIC ALTERATIONS IN PATIENTS WITH BACILLE CALMETTE-GUERIN (BCG) UNRESPONSIVE BLADDER CANCER: TOWARDS TARGETED THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

PD12-09 INHERITED CANCER PREDISPOSITION GENE VARIANTS IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER

The Journal of urology, 2020-04, Vol.203, p.e262-e263

2020

Volltextzugriff (PDF)

Commentary: underutilization of curative-intent therapy for patients with muscle-invasive bladder cancer in Sweden mimics the United States

Translational andrology and urology, 2019-12, Vol.8 (Suppl 5), p.S542-S545

2019

Volltextzugriff (PDF)

Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma – An exploratory analysis

Urologic oncology, 2021-11, Vol.39 (11), p.791.e17-791.e24

2021

Volltextzugriff (PDF)

Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids

The Journal of biological chemistry, 2020-01, Vol.295 (1), p.263

2020

Volltextzugriff (PDF)

Preoperative nomogram predicting 12-year probability of metastatic renal cancer – evaluation in a contemporary cohort

Urologic oncology, 2020-11, Vol.38 (11), p.853.e1-853.e7

2020

Volltextzugriff (PDF)

"Primary" and "secondary" muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes

Translational cancer research, 2019-12, Vol.8 (Suppl 6), p.S642-S644

2019

Volltextzugriff (PDF)

Clinical heterogeneity of polish patients with KAT6B–related disorder

Molecular genetics & genomic medicine, 2023-12, Vol.11 (12), p.e2265-n/a

2023

Volltextzugriff (PDF)

The phenotype‐driven computational analysis yields clinical diagnosis for patients with atypical manifestations of known intellectual disability syndromes

Molecular genetics & genomic medicine, 2020-09, Vol.8 (9), p.e1263-n/a

2020

Volltextzugriff (PDF)

Additional data on the clinical phenotype of Helsmoortel-Van der Aa syndrome associated with a novel truncating mutation in ADNP gene

American journal of medical genetics. Part A, 2016-06, Vol.170A (6), p.1647-1650

2016

Volltextzugriff (PDF)

Complex Heat Exchange in Friction Steam of Brakes

Energies (Basel), 2022-10, Vol.15 (19), p.7412

2022

Volltextzugriff (PDF)

How does terminal 21q22 deletion really manifest? Delineation based on prenatal diagnosis and literature review

Taiwanese journal of obstetrics & gynecology, 2021-11, Vol.60 (6), p.1121-1125

2021

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(62)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Does Delaying Surgical Treatment of BPH Affect Long-Term Outcomes?

Juxtaglomerular Cell Tumor: A Rare, Curable Cause of Hypertension in a Young Patient

Immunotherapy and Checkpoint Inhibitors in Urologic Cancer

Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids

Pan-Urethral Condylomata Acuminata in an Immunocompromised Patient

Abstract A14: Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer

Abstract B20: Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma

PD47-05 PREVALENCE OF ACTIONABLE GENOMIC ALTERATIONS AND THE USE OF TARGETED THERAPY IN METASTATIC UROTHELIAL CARCINOMA

PD47-03 CHARACTERIZING THE LANDSCAPE OF ACTIONABLE GENOMIC ALTERATIONS TO IDENTIFY OPPORTUNITIES FOR TARGETED THERAPY TRIALS IN PATIENTS WITH LOCALIZED BLADDER CANCER

PD12-12 PATIENT MATCHED GENOMIC ANALYSIS OF HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER SPECIMENS PRE- AND POST-BCG IMMUNOTHERAPY

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer

MP63-13 NEXT-GENERATION SEQUENCING REVEALS GENOMIC DIFFERENCES BETWEEN MALE AND FEMALE PATIENTS WITH UROTHELIAL CARCINOMA

MP57-10 CHARACTERIZATION OF MOLECULAR DIFFERENCES BETWEEN SMOKERS AND NON-SMOKERS WITH UROTHELIAL CARCINOMA

MP43-05 THE LANDSCAPE OF CLINICALLY ACTIONABLE GENOMIC ALTERATIONS IN PATIENTS WITH BACILLE CALMETTE-GUERIN (BCG) UNRESPONSIVE BLADDER CANCER: TOWARDS TARGETED THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER

PD12-09 INHERITED CANCER PREDISPOSITION GENE VARIANTS IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER

Commentary: underutilization of curative-intent therapy for patients with muscle-invasive bladder cancer in Sweden mimics the United States

Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma – An exploratory analysis

Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids

Preoperative nomogram predicting 12-year probability of metastatic renal cancer – evaluation in a contemporary cohort

"Primary" and "secondary" muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes

Clinical heterogeneity of polish patients with KAT6B–related disorder

The phenotype‐driven computational analysis yields clinical diagnosis for patients with atypical manifestations of known intellectual disability syndromes

Additional data on the clinical phenotype of Helsmoortel-Van der Aa syndrome associated with a novel truncating mutation in ADNP gene

Complex Heat Exchange in Friction Steam of Brakes

How does terminal 21q22 deletion really manifest? Delineation based on prenatal diagnosis and literature review

Suchergebnisse filtern